Currently, for the squamous type, why would oncologists even bother sending another test (for PD-L1 status) if they can simply prescribe Opdivo? (it's a rhetorical question).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.